Literature DB >> 16879216

A classification of the fibrin network structures formed from the hereditary dysfibrinogens.

T Sugo1, H Endo, M Matsuda, T Ohmori, S Madoiwa, J Mimuro, Y Sakata.   

Abstract

OBJECTIVE: The main objective was to study the relationships of the molecular defects in 38 dysfibrinogens with their fibrin networks. METHODS AND
RESULTS: Scanning electron microscopic analyses revealed that all the fibrins formed under the same conditions had networks composed of either normal thickness fibers or thin fibers, accompanied by a variety of alterations in the network structure and characteristics. We classified these fibrin networks into five classes, designated normal, less-ordered, porous A, porous B and lace-like networks. The dysfibrinogens with defects in fibrinopeptide A release or the E:D binding sites formed normal or less-ordered networks, while those with defects in the D:D association formed porous A networks composed of many tapered terminating fibers, despite having fibers of normal width, and containing many pores or spaces. The porous B and lace-like networks were composed of highly branched thin fibers because of defects in the lateral association among protofibrils, and the major difference between them was the porosity of the porous B networks. All the porous B networks were easily damaged by mechanical stress, whereas the lace-like networks retained high resistance to such stress, indicating that the network strength was not dependent on the fiber width, but on the porosity that led to fragility of the network.
CONCLUSION: Impairment of the D:D association is the major disturbing factor that leads to the formation of porous fibrin networks. The porosity may be introduced by severe impairment of the D:D association, as well as the lateral association, as has often been observed by extra glycosylation or defects in Ca2+ binding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879216     DOI: 10.1111/j.1538-7836.2006.02043.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  A novel fibrinogen variant: dysfibrinogenemia associated with γAsp185Asn substitution.

Authors:  Na Zhou; Peipei Xu; Min Zhou; Yong Xu; Ping Li; Bin Chen; Jian Ouyang; Rongfu Zhou
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

2.  Structure and Function of Trypsin-Loaded Fibrinolytic Liposomes.

Authors:  Anna Tanka-Salamon; Attila Bóta; András Wacha; Judith Mihály; Miklós Lovas; Krasimir Kolev
Journal:  Biomed Res Int       Date:  2017-07-03       Impact factor: 3.411

3.  A novel fibrinogen γ-chain frameshift mutation, p. Cys365Phefs*41, causing hypofibrinogenemia with bleeding phenotype in a Chinese family.

Authors:  Weijie Zhou; Yan Huang; Jie Wei; Jun Li Wang; Boming Huang; Xiaoxuan Zhou; Jie Yan; Yangyang Wu; Faquan Lin; Wangrong Wen
Journal:  Ann Transl Med       Date:  2021-08

4.  A Chinese family with congenital Dysfibrinogenemia carries a heterozygous missense mutation in FGA: Concerning the genetic abnormality and clinical treatment.

Authors:  Jihao Zhou; Peng Zhu; Xinyou Zhang
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

5.  Identification and characterization of novel mutations implicated in congenital fibrinogen disorders.

Authors:  Natalie Smith; Larissa Bornikova; Leila Noetzli; Hugo Guglielmone; Salvador Minoldo; Donald S Backos; Linda Jacobson; Courtney D Thornburg; Miguel Escobar; Tara C White-Adams; Alisa S Wolberg; Marilyn Manco-Johnson; Jorge Di Paola
Journal:  Res Pract Thromb Haemost       Date:  2018-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.